Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) will host a conference call on November 4, 2021, at 5:00 PM ET to discuss Q3 2021 financial results, recent developments, and the full-year outlook. Interested parties can join via telephone or webcast. The call will provide insights into the company's financial performance and strategic direction as it aims to enhance public health. For more details, visit the Emergent website.

Positive

• Scheduled conference call for Q3 earnings to discuss financial results and future outlook.

Negative

• None.

GAITHERSBURG, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 4, 2021 at 5:00 pm eastern time to discuss the financial results for the third quarter of 2021, recent business developments, and financial outlook for full year 2021.

This conference call can be accessed live by telephone or by webcast:

eleconference Information:
Dial in number – toll-free: (855) 766-6521
Dial in number – toll: (262) 912-6157
Conference ID: 2937668

Webcast Information:
Visit https://edge.media-server.com/mmc/p/nitqgk48 for the live webcast.

A replay of the call can be accessed from the Emergent website.

Investor Contact:About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Robert G. Burrows
Vice President, Investor Relations
burrowsr@ebsi.com

Media Contact:
Matt Hartwig
Senior Director, Media Relations
hartwigm@ebsi.com

FAQ

When will Emergent BioSolutions announce its Q3 2021 financial results?

Emergent BioSolutions will announce its Q3 2021 financial results on November 4, 2021.

How can I access the Emergent BioSolutions Q3 2021 conference call?

The Q3 2021 conference call can be accessed by telephone at (855) 766-6521 or via webcast through the Emergent website.

What time is the Emergent BioSolutions Q3 2021 conference call?

The conference call is scheduled for 5:00 PM Eastern Time on November 4, 2021.

What will be discussed in the Emergent BioSolutions Q3 2021 conference call?

The conference call will discuss Q3 2021 financial results, recent business developments, and the financial outlook for the full year 2021.